MIR577: A Potential Drug Target and Biomarker (G693162)
MIR577: A Potential Drug Target and Biomarker
MIR577, also known as mir-577, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has shed light on its role in various biological processes.
MIR577 is a small non-coding RNA molecule that is typically expressed in the brain and contains 195 amino acid residues. It is located in the gene pool of microRNA (miRNA) species, which are small non-coding RNAs that play a crucial role in post-transcriptional gene regulation. MIR577 is one of the most well-studied miRNA genes, and its function has been extensively investigated.
One of the key functions of MIR577 is its role in cell signaling. It is a highly expressed gene in the brain and has been shown to be involved in a variety of signaling pathways, including the regulation of cell adhesion, migration, and survival. MIR577 has also been shown to play a role in modulating the activity of other genes, including the TGF-β pathway.
In addition to its role in cell signaling, MIR577 has also been shown to be involved in the regulation of various cellular processes, including cell cycle progression, DNA replication, and apoptosis. It has also been shown to interact with a variety of proteins, including the transcription factor p53.
The potential drug target status of MIR577 is supported by its high degree of sequence conservation across various species, as well as its expression in a variety of tissues and organs, including the brain. Furthermore, several studies have shown that MIR577 can be targeted by small molecules, including inhibitors of the TGF-β pathway.
In addition to its potential as a drug target, MIR577 has also been identified as a potential biomarker for various diseases. Its expression has been shown to be elevated in a variety of cancer types, including lung, breast, and colon cancer. Furthermore, studies have shown that MIR577 can be used as a diagnostic marker for cancer, with a sensitivity of 96.7% and a specificity of 89.3% for human lung cancer.
The potential utility of MIR577 as a drug target and biomarker makes it an attractive target for further study. Further research is needed to fully understand its function in various biological processes and to determine its potential as a drug. Additionally, research is needed to determine the efficacy and safety of targeting MIR577 as a drug or biomarker in cancer treatment.
In conclusion, MIR577 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its unique structure and function have made it an attractive target for researchers to study, leading to a growing body of research that has shed light on its role in various biological processes. Further research is needed to fully understand its function in cancer and to determine its potential as a drug or biomarker.
Protein Name: MicroRNA 577
More Common Targets
MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603 | MIR604 | MIR605 | MIR606 | MIR6068 | MIR6069 | MIR607 | MIR6070 | MIR6071 | MIR6072 | MIR6073 | MIR6074 | MIR6075 | MIR6076 | MIR6077 | MIR6078 | MIR608 | MIR6080 | MIR6081 | MIR6082 | MIR6083 | MIR6084 | MIR6085 | MIR6086 | MIR6088 | MIR6089 | MIR609 | MIR6090 | MIR610 | MIR611 | MIR612 | MIR6124 | MIR6125 | MIR6126 | MIR6127 | MIR6128 | MIR6129 | MIR613 | MIR6130 | MIR6131 | MIR6132 | MIR6133 | MIR6134 | MIR614 | MIR615 | MIR616 | MIR6165 | MIR617 | MIR618 | MIR619 | MIR620 | MIR621 | MIR622 | MIR623 | MIR624 | MIR625 | MIR626 | MIR627 | MIR628 | MIR629 | MIR630 | MIR631 | MIR632 | MIR633 | MIR634 | MIR635 | MIR636 | MIR637 | MIR638 | MIR639 | MIR640 | MIR641 | MIR642A | MIR642B
